Robuta

https://portal.research.lu.se/en/publications/morphometric-analysis-of-subcortical-structures-in-progressive-su/ Morphometric analysis of subcortical structures in progressive supranuclear palsy: In vivo evidence... morphometric analysis supranuclear palsy structures https://alzprotect.com/news/progressive-supranuclear-palsy-phase-2-platform-clinical-trial-announces-the-selection-of-aadvac1-and-azp2006-for-its-first-two-regimens Alzprotect - Progressive Supranuclear Palsy Phase 2 Platform Clinical Trial announces the selection... Therapeutic solutions for neurodegeneration supranuclear palsy https://www.acebarcelona.org/en/pub-cientificas/tideglusib-reduces-progression-of-brain-atrophy-in-progressive-supranuclear-palsy-in-a-randomized-trial/ Tideglusib reduces progression of brain atrophy in progressive supranuclear palsy in a randomized... Oct 17, 2025 - New scientific study shows that Tideglusib may slow brain atrophy in patients with progressive supranuclear palsy. Research led by Boada M and Lafuente A. https://ora.uniurb.it/handle/11576/2720794 Combined rehabilitation program for postural instability in progressive supranuclear palsy rehabilitation program combined instability progressive https://ayushdhara.in/index.php/ayushdhara/article/view/2488 Clinical Outcomes of Gomutra Bhavitha Chitraka Rasayana in Progressive Supranuclear Palsy: Evidence... clinical outcomes https://www.mdsabstracts.org/abstract/characterizing-the-spectrum-of-non-motor-symptoms-in-progressive-supranuclear-palsy/ Characterizing the spectrum of Non-motor Symptoms in Progressive Supranuclear Palsy - MDS Abstracts Objective: To systematically assess the specific Non-motor symptoms in Progressive Supranuclear Palsy using the Non Motor Symptom assessment scale (NMSS).... https://www.ideac.org/ideac_research/phase-1-trial-of-bepranemab-in-progressive-supranuclear-palsy Phase 1 trial of bepranemab in progressive supranuclear palsy | phase trial progressive